Study of Axial Mobility Exercises in Parkinson Disease

This study has been completed.

First Received: February 24, 2000 Last Updated: June 23, 2005 History of Changes

Sponsored by:	Duke University
Information provided by:	Office of Rare Diseases (ORD)
ClinicalTrials.gov Identifier:	NCT00004760

Purpose

OBJECTIVES:

I. Compare the benefit of exercise versus usual care (no exercise) on impairments and functional limitations in patients with Parkinson disease.

Condition	Intervention
Parkinson Disease	Behavioral: Exercise

Genetics Home Reference related topics: familial paroxysmal nonkinesigenic dyskinesia Parkinson disease

MedlinePlus related topics: Exercise and Physical Fitness Parkinson's Disease

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Educational/Counseling/Training

Further study details as provided by Office of Rare Diseases (ORD):

Estimated Enrollment:	80
Study Start Date:	May 1995
Estimated Study Completion Date:	December 1997

Detailed Description:

PROTOCOL OUTLINE: This is a randomized study. Patients assigned to the Axial Mobility Exercise Program participate 3 times a week for 10 weeks. The program consists of individualized exercises specifically directed toward restoration of axial mobility in the context of functional tasks.

Patients assigned to the control group receive standard care (no exercise).

Eligibility

Ages Eligible for Study:	50 Years to 90 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

PROTOCOL ENTRY CRITERIA:

--Disease Characteristics-- Stage 2 or 3 Parkinson disease (Hoehn/Yahr scale) Able to ambulate independently Able to function independently in home Moderate rigidity No moderate or severe tremor --Prior/Concurrent Therapy-- Concurrent stable pharmacologic regimen required --Patient Characteristics-- Cardiovascular: No unstable angina Other: No psychiatric or medical contraindication to exercise, e.g., dementia, hip fracture; no other neurologic disorder, e.g., stroke, multiple sclerosis; resides within 30 miles of Duke University

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004760

Sponsors and Collaborators

Duke University

Investigators

Study Chair:

Margaret Schenkman

Duke University

More Information

No publications provided

Study ID Numbers:	199/11694, DUMC-722955R2
Study First Received:	February 24, 2000
Last Updated:	June 23, 2005
ClinicalTrials.gov Identifier:	NCT00004760 History of Changes
Health Authority:	Unspecified

Keywords provided by Office of Rare Diseases (ORD):

Parkinson disease
Neurologic and psychiatric disorders
Rare disease

Study placed in the following topic categories:

Ganglion Cysts
Movement Disorders
Mental Disorders
Parkinson Disease
Basal Ganglia Diseases

Rare Diseases
Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

Additional relevant MeSH terms:

Movement Disorders
Parkinson Disease
Nervous System Diseases
Basal Ganglia Diseases

Central Nervous System Diseases
Parkinsonian Disorders
Neurodegenerative Diseases
Brain Diseases

ClinicalTrials.gov processed this record on May 07, 2009